Description
Disease Indications
Hypercholesterolemia
Manufacturer
Novartis
Usage
Subcutaneous
Medicine approved by
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Pharmaceuticals and Medical Devices Agency (PMDA)
Leqvio (inclisiran)
$2,000.00
Leqvio (inclisiran) is a medication used to reduce cholesterol levels in adults with primary hypercholesterolaemia or mixed dyslipidaemia.
Additional information
| Package Pre-filled syringe | 1 syringe of 284 mg/1.5 mL |
|---|
Related products
-
Ozempic (semaglutide)
$200.00 Select options This product has multiple variants. The options may be chosen on the product page -
Skytrofa (lonapegsomatropin-tcgd)
Price range: $1,500.00 through $2,000.00 Select options This product has multiple variants. The options may be chosen on the product page -
Zegalogue (dasiglucagon)
Price range: $300.00 through $600.00 Select options This product has multiple variants. The options may be chosen on the product page -
Waylivra (volanesorsen)
$10,000.00 Select options This product has multiple variants. The options may be chosen on the product page
Reviews
There are no reviews yet.